Axon Enterprise (AXON) News Today

Virtu Financial LLC reduced its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 35.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,759 shares of the biotechnology company's stock after selling 1,524

Axon Enterprise (NASDAQ:AXON) Hits New 1-Year High at $391.00

Resolute Capital Asset Partners LLC bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The fund bought 10,000 shares of the biotechnology company's stock, valued at approximately $2,9

SYSTM Wealth Solutions LLC increased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 86.1% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,844 shares of the biotechnology company's stock after purchasing an add

Plato Investment Management Ltd purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 1,799 shares of the biotechnology company's stock, valued at approximately

Forsta AP Fonden decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 31.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,800 shares of the biotechnology company's

William Blair Investment Management LLC lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 27.1% in the second quarter, according to its most recent filing with the SEC. The firm owned 716,967 shares of the biotechnology company's stock after selling 265,858 sha

Axon Enterprise (NASDAQ:AXON) Hits New 52-Week High After Analyst Upgrade

Nicholas Investment Partners LP grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 76.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,054 shares of the biotechnology company's stock after purchasi

Axon Enterprise, Inc. (NASDAQ:AXON - Get Free Report) CFO Brittany Bagley sold 4,338 shares of the business's stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the sale, the chief financial officer now owns 98,825 shares of the company's stock, valued at approximately $37,449,733.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

JMP Securities raised their price target on Axon Enterprise from $375.00 to $430.00 and gave the company an "outperform" rating in a report on Thursday.

Axon Enterprise (NASDAQ:AXON) Sees Large Volume Increase

Andra AP fonden acquired a new position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 21,500 shares of the biotechnology company'

Ground Swell Capital LLC increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 246.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,474 shares of the biotechnology company's stock

Axon Enterprise, Inc. (NASDAQ:AXON - Get Free Report) President Joshua Isner sold 25,811 shares of the firm's stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the completion of the transaction, the president now directly owns 228,166 shares of the company's stock, valued at $82,103,253.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Chesapeake Capital Corp IL trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 50.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,339 shares of the

Robert W. Baird raised their price objective on Axon Enterprise from $360.00 to $400.00 and gave the company an "outperform" rating in a research note on Tuesday.

JMP Securities reaffirmed a "market outperform" rating and issued a $375.00 target price on shares of Axon Enterprise in a research report on Monday.

Natixis Advisors LLC lifted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 12.6% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 28,840 shares of the biotechnology company's stock a

Rhumbline Advisers boosted its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 1.5% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 150,700 shares of the biotechnology company's stock after buying an a